Upstream Bioprocessing Update – Full SpotlightPublished: May 9, 2019
GUEST EDITOR: Alan Smith, Bellicum
Optimizing and automating scalable bioreactors and cell culture platforms for the reliable, high quality production of cells and viral vectors alike is an area of tremendous activity and innovation in cell & gene therapy. However, this is driven by a most pressing need to advance beyond current technological limitations in order to meet burgeoning demand and to better control manufacturing costs, timelines and quality.
You can download the full Spotlight on Upstream Bioprocessing free of charge – simply login or register here to become a member